페이지 선택

COVID-19

 

 

Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus, originated from the Wuhan region of Hubei province in China late in 2019.

 

AffinityImmuno has been involved in developing research tools to accelerate the fight against SARS-CoV-2 since February 2020 when we performed our first immunizations to generate research antibodies.

COVID-19 Spike Protein Antibodies

 

AffinityImmuno was among the first suppliers of antibodies to SARS-CoV-2 by immunizing our lay hen flock beginning in February 2020 to generate polyclonal antibodies to:
COVID-19 Spike Antibody

ab-131-291

COVID-19 Spike S1 Antibody

ab-131-292

COVID-19 Spike S2 Antibody

ab-131-293

Affinity purified and antibody pairs

 

 

In addition to bulk polyclonal antibodies, we have the following affinity purified and antibody pairs:
5 Kits – COVID-19 Spike Capture and Detection (HRP conjugate) ELISA pair with calibrator

ab-131-295-PAIR

Affinity Purified SARS-COV-2 Spike S2 Domain Antibody

ab-131-294

Gold Conjugated Affinity Purified SARS-COV-2 Spike S2 Domain Antibody

ab-131-294-gold

HRP Conjugated Affinity Purified SARS-COV-2 Spike S2 Domain Antibody

ab-131-294-hrp

Virus Neutralization Test

SARS-CoV-2 surrogate Virus Neutralizing Test (sVNT) (spike protein/ ACE2 ligand binding assay) COVID-19 sVNT

EL-1611-32214